![Adam Waldman](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Adam Waldman
Corporate Officer/Principal bij TG THERAPEUTICS, INC.
Profiel
Adam Waldman is currently the Chief Commercial Officer at TG Therapeutics, Inc. He previously worked at Celgene Corp.
as the Head of Haematology & Oncology Marketing.
Waldman received an undergraduate degree from Rutgers State University of New Jersey and an MBA from the University of Rochester Simon Business School.
Actieve functies van Adam Waldman
Bedrijven | Functie | Begin |
---|---|---|
TG THERAPEUTICS, INC. | Corporate Officer/Principal | 04-06-2018 |
Eerdere bekende functies van Adam Waldman
Bedrijven | Functie | Einde |
---|---|---|
CELGENE | Corporate Officer/Principal | - |
Opleiding van Adam Waldman
University of Rochester Simon Business School | Masters Business Admin |
Rutgers State University of New Jersey | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
TG THERAPEUTICS, INC. | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Celgene Corp.
![]() Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |